Prosecution Insights
Prosecution Insights
125 pending office actions • 53 art units • 117 examiners • 0 of 125 (0%) have an AI response strategy ready • 119 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 59 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 59 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 19 (15%) |
| §103 only | 32 (26%) |
| §102 only | 3 (2%) |
| §112 only | 6 (5%) |
| Double-patenting only | 3 (2%) |
| Double-patenting + other | 15 (12%) |
| Multi-statute (no §101) | 46 (37%) |
| No statute on record | 1 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, YIE CHIA | 3 | 70.6% | +46.0% |
| BARRON, SEAN C | 2 | 53.3% | +30.6% |
| SKELDING, ZACHARY S | 2 | 59.8% | +41.0% |
| VIRK, ADIL PARTAP S | 2 | 48.0% | +43.4% |
| POHNERT, STEVEN C | 2 | 12.2% | +18.7% |
| FETTEROLF, BRANDON J | 2 | 51.4% | +17.1% |
| PATEL, SHEFALI DILIP | 2 | 58.3% | +27.5% |
| MOHAMMED, SHAHDEEP | 1 | 51.5% | +57.0% |
| BOWMAN, ANDREW J | 1 | 65.6% | +13.2% |
| HOAG, MITCHELL BRAIN | 1 | 70.5% | +17.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17996911 | SYSTEMS AND METHODS FOR ADMINISTERING A SMELL TEST FOR SARS CORONAVIRUSES AND COVID-19 | TOTH, KAREN E | 190d overdue |
| 18024179 | METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS | TRAN, DUY ANH | 132d overdue |
| 18014580 | INTERLEUKIN 33 (IL-33) INHIBITION FOR TREATMENT OF CANCER, FIBROSIS AND INFLAMMATION | HERNANDEZ, JACKSON J | 91d overdue |
| 17923838 | Translation Blockers Repurposed for COVID-19 Therapy | ANDERSON, JAMES D | 72d overdue |
| 18571154 | METHODS TO CHARACTERIZE FUNCTIONAL AND DYSFUNCTIONAL ACUTE INFLAMMATORY RESPONSES TO PATHOLOGIC PROCESSES | HOLCOMB, MARK | 56d overdue |
| 18021625 | PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF | POHNERT, STEVEN C | 52d overdue |
| 18856679 | MATERIALS AND METHODS FOR LUMINESCENCE-BASED CARBON DIOXIDE SENSING | CELESTINE, NYROBI I | 49d overdue |
| 17784935 | ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF | WESTON, ALYSSA G | 16d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18010695 | TARGETED ABERRANT ALPHA-SYNUCLEIN SPECIES AND INDUCED UBIQUITINATION AND PROTEOSOMAL CLEARANCE VIA CO-RECRUITMENT OF AN E3-LIGASE SYSTEM | FETTEROLF, BRANDON J | 160d overdue |
| 16944588 | SYSTEMS AND METHODS THAT FACILITATE TATTOO REMOVAL | PATEL, SHEFALI DILIP | 72d overdue |
| 18021625 | PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF | POHNERT, STEVEN C | 52d overdue |
| 16349405 | SYSTEMS AND METHODS FOR MULTI-DISTANCE, MULTI-WAVELENGTH DIFFUSE CORRELATION SPECTROSCOPY | VIRK, ADIL PARTAP S | 10d overdue |
| 17912272 | TARGETED DEGRADERS OF ABERRANT TAU BASED ON THE PET TRACER PBB3 | FETTEROLF, BRANDON J | 7d |
| 17627975 | SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER | LEE, YIE CHIA | 78d |
| 17401623 | SYSTEMS AND METHODS FOR REMOVING EXOGENOUS PARTICLES FROM THE SKIN OF A PATIENT | PATEL, SHEFALI DILIP | 79d |
| 19231352 | MINITUARIZED INTRAVASCULAR FLUORESCENCE-ULTRASOUND IMAGING CATHETER | MOHAMMED, SHAHDEEP | — |
| Art Unit | Apps |
|---|---|
| 3797 | 6 |
| 3798 | 5 |
| 1645 | 5 |
| 1683 | 5 |
| 1618 | 4 |
| 3791 | 4 |
| 1653 | 4 |
| 1642 | 4 |
| 3783 | 4 |
| 1631 | 4 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19231352 | MINITUARIZED INTRAVASCULAR FLUORESCENCE-ULTRASOUND IMAGING CATHETER | MOHAMMED, SHAHDEEP | 3797 | §102DP | Non-Final OA | — | Pending | Jun 06, 2025 |
| 19229786 | METHODS OF MAKING THERAPEUTIC POLYMERIC MATERIAL | BOWMAN, ANDREW J | 1717 | DP | Non-Final OA | — | Pending | Jun 05, 2025 |
| 19127809 | SYSTEMS AND METHODS FOR LONG HAIR TRANSPLANTATION | HOAG, MITCHELL BRAIN | — | §103 | Non-Final OA | — | Pending | May 07, 2025 |
| 19171160 | LIPID NANOPARTICLES FOR THE TREATMENT OF VASCULAR DISEASES | WESTERBERG, NISSA M | 1618 | §103DPOther | Non-Final OA | — | Pending | Apr 04, 2025 |
| 19029949 | SYSTEMS AND METHODS FOR MICRO-OPTICAL COHERENCE TOMOGRAPHY IMAGING OF THE COCHLEA | KLEIN, BROOKE L | 3797 | §102§103 | Final Rejection | 13d | Pending | Jan 17, 2025 |
| 18862293 | SYSTEMS AND METHODS FOR ELECTROPHYSIOLOGICAL SIGNAL RECORDING AND POSITION OR MOTION MONITORING DURING MAGNETIC RESONANCE IMAGING | JASANI, ASHISH SHIRISH | 3798 | §102 | Final Rejection | 8d | Pending | Nov 01, 2024 |
| 18861837 | SYSTEM FOR AND METHOD OF ZINC IMAGING FOR MARGIN ASSESSMENT DURING BREAST CONSERVING SURGERY | MACCAGNO, PIERRE L | 3687 | §101§103 | Final Rejection | — | Pending | Oct 30, 2024 |
| 18858643 | DEEP LEARNING BASED IMAGE RECONSTRUCTION | YANG, JIANXUN | — | §103 | Non-Final OA | — | Pending | Oct 21, 2024 |
| 18856679 | MATERIALS AND METHODS FOR LUMINESCENCE-BASED CARBON DIOXIDE SENSING | CELESTINE, NYROBI I | 3798 | §102§103 | Non-Final OA | 49d overdue | Pending | Oct 14, 2024 |
| 18848815 | METHOD AND APPARATUS FOR DERMATOLOGICAL TREATMENT | MARSH, OWEN LEWIS | 3796 | §102§103§112 | Non-Final OA | 42d | Pending | Sep 19, 2024 |
| 18889325 | Methods and Compositions for Preserving Tissues and Organs | CLARKE, TRENT R | 1651 | §103§112 | Non-Final OA | — | Pending | Sep 18, 2024 |
| 18845371 | SYSTEMS AND METHODS FOR IN VIVO CHARACTERIZATION OF TUBULAR SOFT TISSUES | NGUYEN, HUONG Q | — | §101§103§112 | Non-Final OA | — | Pending | Sep 09, 2024 |
| 18818122 | DRUG ELUTING POLYMER COMPOSED OF BIODEGRADABLE POLYMERS APPLIED TO SURFACE OF MEDICAL DEVICE | FALKOWITZ, ANNA R | — | DP | Non-Final OA | — | Pending | Aug 28, 2024 |
| 18838347 | NEURAL PROGENITOR CELL COMPOSITIONS AND METHODS OF USING THE SAME | KASAYAN, KATRIEL BARCELLANO | — | §101§103§112 | Non-Final OA | — | Pending | Aug 14, 2024 |
| 18796175 | SYSTEMS AND METHODS FOR HAIR TRANSPLANT | LONG, SARAH A | 3771 | §103§112 | Non-Final OA | 29d | Pending | Aug 06, 2024 |
| 18794131 | PROBIOTICS COMPOSITIONS AND METHOD OF USING THE SAME TO ENHANCE GROWTH AND SOCIAL FUNCTION IN CHILDREN | EDWARDS, JESSICA FAYE | — | §102§103§112DP | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18730214 | IMMUNOMODULATORY LIPIDS AND USES THEREOF | REILLY, SOPHIA JANE | — | §101§102§103§112 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18771884 | SYSTEM AND METHOD FOR CHARACTERIZING BRAIN STATES DURING GENERAL ANESTHESIA AND SEDATION USING PHASE-AMPLITUDE MODULATION | BERHANU, ETSUB D | 3791 | §103§112 | Non-Final OA | 16d | Pending | Jul 12, 2024 |
| 18764634 | RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci | NOAKES, SUZANNE MARIE | 1656 | DP | Final Rejection | — | Pending | Jul 05, 2024 |
| 18757819 | METHODS AND SYSTEMS FOR MODULATING UNCONSCIOUSNESS OR ANESTHESIA IN A SUBJECT | ALTER MORSCHAUSER, ALYSSA MARGO | — | §102§103 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18719106 | SYSTEM AND METHOD FOR CLINICAL DISORDER ASSESSMENT | OGLES, MATTHEW ERIC | 3791 | §101§102§103§112 | Non-Final OA | — | Pending | Jun 12, 2024 |
| 18705368 | SYSTEM AND METHOD FOR INTRAOPERATIVE LIFETIME IMAGING | LI, JOHN DENNY | 3798 | §112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18704670 | ATRAUMATIC CATHETER | WRUBLESKI, MATTHEW JAMES | 3781 | §103§112 | Final Rejection | — | Pending | Apr 25, 2024 |
| 18645005 | USE OF MULLERIAN INHIBITING SUBSTANCE (MIS) PROTEINS FOR CONTRACEPTION AND OVARIAN RESERVE PRESERVATION | BORGEEST, CHRISTINA M | 1675 | §112DPOther | Non-Final OA | — | Pending | Apr 24, 2024 |
| 18703879 | METHODS AND COMPOSITION FOR THE TREATMENT OF PRADER-WILLI SYNDROME SYMPTOMS | DEVI, SARVAMANGALA | 1645 | §102§112DP | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18639238 | ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF | BERKE-SCHLESSEL, DAVID W | 1651 | §112 | Non-Final OA | 26d | Pending | Apr 18, 2024 |
| 18699271 | ACCESS DEVICE | VU, QUYNH-NHU HOANG | — | §103 | Non-Final OA | — | Pending | Apr 06, 2024 |
| 18618523 | DI-CUMYL PEROXIDE CROSSLINKING OF UHMWPE | BOYLE, ROBERT C | 1764 | §103Other | Final Rejection | 15d overdue | Pending | Mar 27, 2024 |
| 18605332 | ENZYMATIC METHODS AND COMPOSITIONS FOR POLYMERIZATION OF PHOSPHORAMIDATE AND THIOPHOSPHORAMIDATE-LINKED DNA | HUDSON, AMY ROSE | — | §102§103§112DP | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18602622 | GENE THERAPY FOR TUBEROUS SCLEROSIS | VIVLEMORE, TRACY ANN | — | §102§112DP | Non-Final OA | — | Pending | Mar 12, 2024 |
| 18686018 | CONNECTOR ROD FOR CORRECTION OF SPINAL DEFORMITY | MERENE, JAN CHRISTOP L | 3773 | §102 | Final Rejection | — | Pending | Feb 23, 2024 |
| 18444413 | INJECTABLE SLURRIES AND METHODS OF MANUFACTURING AND USING THE SAME | ROSENTHAL, ANDREW S | 1613 | §103 | Non-Final OA | 63d | Pending | Feb 16, 2024 |
| 18428820 | COMPOSITION FOR TREATING GOUT CONTAINING CYCLODEXTRIN-CONJUGATED POLYMER NANO-DRUG AND METHOD FOR TREATING GOUT | FUBARA, BLESSING M | 1613 | §103 | Non-Final OA | 17d overdue | Pending | Jan 31, 2024 |
| 18417527 | METHODS FOR REACTIVATING GENES ON THE INACTIVE X CHROMOSOME | WHITEMAN, BRIAN A | 1636 | §112DP | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18576696 | COMPOSITIONS AND METHODS FOR DECREASING PIGMENTATION | GREENE, IVAN A | 1619 | §102§103 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18396156 | Digital Analysis of Circulating Tumor Cells in Blood Samples | GROSS, CHRISTOPHER M | 1684 | §112Other | Final Rejection | — | Pending | Dec 26, 2023 |
| 18573372 | CHROMANE IMAGING LIGANDS | PECKHAM, RICHARD GRANT | 1627 | §103 | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18572580 | USE OF EXTENSIVELY HYDROLYSED PROTEIN | MCCLAIN, TYNESHA L. | 1793 | §102§103§112 | Non-Final OA | 21d | Pending | Dec 20, 2023 |
| 18543705 | Regeneration of a Functional Pulmonary Vascular Bed | PYLA, EVELYN Y | 1633 | §102§103§112 | Non-Final OA | — | Pending | Dec 18, 2023 |
| 18571154 | METHODS TO CHARACTERIZE FUNCTIONAL AND DYSFUNCTIONAL ACUTE INFLAMMATORY RESPONSES TO PATHOLOGIC PROCESSES | HOLCOMB, MARK | 3685 | §101§103 | Final Rejection | 56d overdue | Pending | Dec 15, 2023 |
| 18568589 | PRE-EPICARDIAL CELLS AND USES THEREOF | BARRON, SEAN C | 1653 | §103§112 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18568797 | METHODS AND COMPOSITIONS FOR MODULATING STING SIGNALING AND INNATE IMMUNE RESPONSES | PERSONS, JENNA L | — | §101§102§103§112 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18567197 | MATERIALS AND METHODS FOR DIFFERENTIATING CREB REGULATEDTRANSCRIPTION COACTIVATOR 3 | LEE, YIE CHIA | — | §112 | Non-Final OA | — | Pending | Dec 05, 2023 |
| 18511459 | Minimal Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules | JOHNSON, ALLISON MARIE | 1638 | §102§103§112DP | Non-Final OA | — | Pending | Nov 16, 2023 |
| 18511486 | Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules | WANG, RUIXUE | 1632 | §103§112 | Non-Final OA | 75d | Pending | Nov 16, 2023 |
| 18507778 | Compositions and Methods for Targeting Cancer Stem Cells | COOK, LISA V | 1642 | §103§112DP | Non-Final OA | — | Pending | Nov 13, 2023 |
| 18290135 | MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES | SHOMER, ISAAC | 1612 | §102§103§112 | Non-Final OA | — | Pending | Nov 09, 2023 |
| 18560000 | Methods and Compositions for Extending Organ and Tissue Preservation | VAN BUREN, LAUREN K | 1638 | §102§103§112Other | Non-Final OA | 10d overdue | Pending | Nov 09, 2023 |
| 18289836 | Targeting Extracellular Matrix Proteins to Regulate NK Cell Function in Peripheral Tissues | PRIEST, JESSICA MARIE | 1642 | §102§112Other | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18499179 | SYSTEMS AND METHODS FOR SUPERVISED REMOTE IMAGING-GUIDED INTERVENTION | POPESCU, GABRIEL VICTOR | 3797 | §103 | Final Rejection | — | Pending | Oct 31, 2023 |
| 18555407 | PHOTOCHEMICAL TISSUE BONDING CLAMP AND IRRADIATION CHAMBER AND METHOD OF USE THEREOF | DIETRICH, JOSEPH M | 3796 | §103 | Final Rejection | 15d overdue | Pending | Oct 13, 2023 |
| 18554536 | SYSTEMS AND METHODS FOR INCREASING METABOLIC RATES | FLANAGAN, BEVERLY MEINDL | 3794 | §103 | Final Rejection | — | Pending | Oct 09, 2023 |
| 18552972 | COMPACT SIGNAL FEATURE EXTRACTION FROM MULTI-CONTRAST MAGNETIC RESONANCE IMAGES USING SUBSPACE RECONSTRUCTION | DULANEY, BENJAMIN O | 2683 | §102§103 | Final Rejection | — | Pending | Sep 28, 2023 |
| 18477532 | CHIMERIC ANTIGEN RECEPTOR T CELLS TARGETING THE TUMOR MICROENVIRONMENT | SKELDING, ZACHARY S | 1644 | §102§103DP | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18468298 | COMPOSITIONS AND METHODS FOR CHARACTERIZING LYMPHOMA AND RELATED CONDITIONS | KIM, YOUNG J | 1681 | §101§102§103§112 | Non-Final OA | 83d | Pending | Sep 15, 2023 |
| 18282421 | Compositions and Methods for the Treatment of Conditions Associated with Nucleotide Repeat Expansion | REGA, KYLE THOMAS | 1636 | §102§103§112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18459672 | METHODS FOR DETERMINING A NUCLEOTIDE SEQUENCE CONTIGUOUS TO A KNOWN TARGET NUCLEOTIDE SEQUENCE | BERTAGNA, ANGELA MARIE | 1681 | §112DP | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18279162 | COMPOUNDS FOR BRAIN IMAGING | BAEK, JONGHWAN NMN | 1618 | §103 | Non-Final OA | 83d | Pending | Aug 28, 2023 |
| 18547917 | METHODS AND SYSTEMS FOR SAFE INJECTION OF DERMAL FILLER PROCEDURES | BRANDT, DAVID NELSON | 3783 | §102§103§112 | Non-Final OA | 20d | Pending | Aug 25, 2023 |
| 18547969 | PHOTO-ECMO APPARATUS, SYSTEMS, AND METHODS | LE, QUYNH DAO | 3781 | §103 | Non-Final OA | 26d | Pending | Aug 25, 2023 |
| 18547258 | HIGH-THROUGHPUT ASSESSMENT OF EXOGENOUS POLYNUCLEOTIDE- OR POLYPEPTIDE-MEDIATED TRANSCRIPTOME PERTURBATIONS | BELLAH, JEFFREY LAWRENCE | 1683 | §102§103§112 | Non-Final OA | — | Pending | Aug 21, 2023 |
| 18274641 | FC-ENHANCED ANTIBODIES FOR PREVENTION AND TREATMENT OF EBOLA VIRUS INFECTION | ALLEN, MICHAEL D | 1671 | §103§112 | Non-Final OA | 42d | Pending | Jul 27, 2023 |
| 18274435 | Methods for Treating Autism Spectrum Disorder | EDUN, DEAN NAWAAB | 3797 | §103§112 | Final Rejection | — | Pending | Jul 26, 2023 |
| 18273395 | ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ANTIBODIES | LEE, YIE CHIA | 1642 | §102§103§112Other | Non-Final OA | — | Pending | Jul 20, 2023 |
| 18273466 | T CELL-DIRECTED ANTI-CANCER VACCINES AGAINST COMMENSAL VIRUSES FOR TREATING MUCOSAL CARCINOMAS | JADHAO, SAMADHAN JAISING | 1672 | §102§103§112DP | Non-Final OA | — | Pending | Jul 20, 2023 |
| 18270611 | METHODS AND COMPOSITION FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER | ZEMAN, ROBERT A | 1645 | §103 | Final Rejection | — | Pending | Jun 30, 2023 |
| 18325332 | Systemic Delivery of Polypeptides | KELLY, ROBERT M | 1638 | §112Other | Non-Final OA | 9d | Pending | May 30, 2023 |
| 18251878 | BLOOD TRANSFER SHIELD AND METHODS OF USE | NGO, MEAGAN N | 3781 | §103 | Non-Final OA | 1d overdue | Pending | May 04, 2023 |
| 18035269 | METHODS FOR IDENTIFYING DRIVERS OF IMMUNE RESPONSES USING MOLECULAR EXPRESSION SIGNATURES OF IMMUNOMODULATING AGENTS | BUNKER, AMY M | 1684 | §102§103§112 | Non-Final OA | — | Pending | May 03, 2023 |
| 18035174 | THERAPEUTIC, RADIOLABELED NANOPARTICLES AND METHODS OF USE THEREOF | PEEBLES, KATHERINE | 1617 | §103§112Other | Final Rejection | 42d | Pending | May 03, 2023 |
| 18142129 | GLYCOENGINEERING | SKELDING, ZACHARY S | 1644 | §101§103DP | Non-Final OA | — | Pending | May 02, 2023 |
| 18298212 | SYSTEM AND METHODS FOR TRANSMISSION OF NON-DIFFRACTING ACOUSTIC BEAMS | VIRK, ADIL PARTAP S | 3798 | §102§103§112 | Non-Final OA | — | Pending | Apr 10, 2023 |
| 18030876 | PEPTIDE INHIBITORS OF GLIOMA-ASSOCIATED ONCOGENE DERIVED FROM THE COILED-COIL DIMERIZATION DOMAIN OF Kif7 | REYNOLDS, FRED H | 1658 | §101§112 | Non-Final OA | — | Pending | Apr 07, 2023 |
| 18030427 | INTRATUMORAL AND SYSTEMIC IMMUNIZATION USING FRACTIONAL DAMAGE-CREATING DEVICE WITH CHECKPOINT MOLECULES FOR CANCER THERAPY | PRICE, NATHAN R | 3783 | §103§112 | Non-Final OA | 27d | Pending | Apr 05, 2023 |
| 18127884 | SYSTEMS AND METHODS FOR NONCONTACT ULTRASOUND IMAGING | COOK, CHRISTOPHER L | 3797 | §103§112 | Final Rejection | — | Pending | Mar 29, 2023 |
| 18028379 | METHODS FOR EVALUATING MIS-C ASSOCIATED WITH COVID-19 | RAMIREZ, ALEX | 1798 | §101§102§103§112 | Final Rejection | 4d overdue | Pending | Mar 24, 2023 |
| 18027696 | BCG VACCINATIONS FOR PREVENTION OF COVID-19 AND OTHER INFECTIOUS DISEASES | GANGLE, BRIAN J | 1645 | §102Other | Final Rejection | — | Pending | Mar 22, 2023 |
| 18024179 | METHODS FOR IDENTIFYING CROSS-MODAL FEATURES FROM SPATIALLY RESOLVED DATA SETS | TRAN, DUY ANH | 2674 | §101§102§103Other | Final Rejection | 132d overdue | Pending | Mar 01, 2023 |
| 18024182 | COMPOSITIONS AND METHODS FOR TREATING THERAPY RESISTANT CANCER | SHIN, DANA H | 1635 | §102§103 | Non-Final OA | — | Pending | Mar 01, 2023 |
| 18021625 | PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF | POHNERT, STEVEN C | 1683 | §101§112 | Final Rejection | 52d overdue | Pending | Feb 16, 2023 |
| 18169695 | HEMOSTATIC NANOPARTICLES FOR THE TREATMENT OF NON-COMPRESSIBLE HEMORRHAGE AND INTERNAL BLEEDING | STEVENS, MARK V | 1613 | §101§102§103§112 | Non-Final OA | 14d | Pending | Feb 15, 2023 |
| 18019720 | Human XIST Antisense Oligonucleotides for X Reactivation Therapy | CHONG, KIMBERLY | 1636 | §102§112Other | Non-Final OA | 27d | Pending | Feb 03, 2023 |
| 18014580 | INTERLEUKIN 33 (IL-33) INHIBITION FOR TREATMENT OF CANCER, FIBROSIS AND INFLAMMATION | HERNANDEZ, JACKSON J | 1627 | §102§103§112 | Non-Final OA | 91d overdue | Pending | Jan 05, 2023 |
| 18010695 | TARGETED ABERRANT ALPHA-SYNUCLEIN SPECIES AND INDUCED UBIQUITINATION AND PROTEOSOMAL CLEARANCE VIA CO-RECRUITMENT OF AN E3-LIGASE SYSTEM | FETTEROLF, BRANDON J | 1626 | §103 | Final Rejection | 160d overdue | Pending | Dec 15, 2022 |
| 18007822 | METHODS OF TREATING A CORONAVIRUS INFECTION | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Non-Final OA | 3d overdue | Pending | Dec 02, 2022 |
| 18000222 | SINGLE CELL COMBINATORIAL INDEXING FROM AMPLIFIED NUCLEIC ACIDS | CASH, KAILEY ELIZABETH | 1683 | §103 | Final Rejection | — | Pending | Nov 29, 2022 |
| 17923838 | Translation Blockers Repurposed for COVID-19 Therapy | ANDERSON, JAMES D | 1629 | §102§112 | Non-Final OA | 72d overdue | Pending | Nov 07, 2022 |
| 18049223 | Ice Nucleation Formulations for Cryopreservation and Stabilization of Biologics | TICHY, JENNIFER M.H. | 1653 | §112 | Final Rejection | — | Pending | Oct 24, 2022 |
| 17996911 | SYSTEMS AND METHODS FOR ADMINISTERING A SMELL TEST FOR SARS CORONAVIRUSES AND COVID-19 | TOTH, KAREN E | 3791 | §101§102§103§112 | Non-Final OA | 190d overdue | Pending | Oct 21, 2022 |
| 17971073 | SYSTEMS AND METHODS FOR GUIDED INTERVENTION | TALTY, MARIA CHRISTINA | 3797 | §102§103 | Non-Final OA | 70d | Pending | Oct 21, 2022 |
| 17919848 | Fluorinated Derivatives of Gabapentin and Methods of Use Thereof | DONOHUE, SEAN R | 1618 | §103 | Non-Final OA | 29d overdue | Pending | Oct 19, 2022 |
| 18046327 | TAU MODULATORS AND METHODS AND COMPOSITIONS FOR DELIVERY THEREOF | NGUYEN, QUANG | 1631 | §102§103§112 | Non-Final OA | — | Pending | Oct 13, 2022 |
| 17912272 | TARGETED DEGRADERS OF ABERRANT TAU BASED ON THE PET TRACER PBB3 | FETTEROLF, BRANDON J | 1626 | §103 | Final Rejection | 7d | Pending | Sep 16, 2022 |
| 17908810 | METHODS AND SYSTEMS TO PRINT AND MATURE TISSUES OVER TIME IN A THREE-DIMENSIONAL SUPPORT MATRIX | NGUYEN, NGHI V | 1653 | §103 | Non-Final OA | 80d overdue | Pending | Sep 01, 2022 |
| 17904568 | METHODS FOR DETECTING NTRK GENE FUSION USING RNA IN SITU HYBRIDIZATION | SWITZER, JULIET CAROLINE | 1682 | §103 | Final Rejection | 31d overdue | Pending | Aug 18, 2022 |
| 17889811 | Cellular Coding Constructs Providing Identification of Cellular Entities | KAUP, SAHANA S | 1612 | §102§103Other | Non-Final OA | 39d | Pending | Aug 17, 2022 |
| 17799164 | MONITORING VIABILITY OF ORGANS FOR TRANSPLANTATION | GABEL, GAILENE | 1678 | §102§112Other | Non-Final OA | 14d | Pending | Aug 11, 2022 |
| 17794520 | METHODS TO CHARACTERIZE ENZYMES FOR GENOME ENGINEERING | BOESEN, CHRISTIAN C | 1684 | §101§102 | Non-Final OA | — | Pending | Jul 21, 2022 |
| 17852663 | THREE DIMENSIONAL MICROTISSUE BIOPRINTER | OCHYLSKI, RYAN M | 1743 | §103 | Non-Final OA | 3d overdue | Pending | Jun 29, 2022 |
| 17784935 | ENGINEERED IMMUNE CELLS WITH REDUCED TOXICITY AND USES THEREOF | WESTON, ALYSSA G | 1633 | §102§103§112 | Final Rejection | 16d overdue | Pending | Jun 13, 2022 |
| 17782369 | COMPOSITIONS AND METHODS FOR TUNABLE MAGNETIC NANOPARTICLES | MEJIAS, SAMANTHA LEE | 1618 | §103§112Other | Non-Final OA | 3d overdue | Pending | Jun 03, 2022 |
| 17781279 | Nerve Xenografts and Related Methods | BARRON, SEAN C | 1653 | §103 | Non-Final OA | — | Pending | May 31, 2022 |
| 17779372 | SYSTEM AND METHOD FOR ACTIVATING GENE EXPRESSION | PAULUS, ERIN VIRGINIA | 1631 | §103 | Final Rejection | — | Pending | May 24, 2022 |
| 17741166 | CHIMERIC ANTIGEN RECEPTORS TARGETING CD37 | EDGINGTONGIORDANO, FRANCESCA | 1643 | §102§103 | Final Rejection | 21d | Pending | May 10, 2022 |
| 17767140 | COMPOSITIONS AND METHODS FOR PULMONARY SURFACTANT-BIOMIMETIC NANOPARTICLES | HAGOPIAN, CASEY SHEA | 1617 | §102§112 | Non-Final OA | — | Pending | Apr 07, 2022 |
| 17689117 | METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY | ABBAS, SYED JARAR | 1645 | §102§112 | Non-Final OA | 14d | Pending | Mar 08, 2022 |
| 17638543 | Dynamic Profiling of Antitumor Activity of CAR T Cells Using Micropatterned tumor Array Devices | KWAK, DEAN P | 1798 | §102§103 | Final Rejection | 8d overdue | Pending | Feb 25, 2022 |
| 17669904 | DIAGNOSIS AND TREATMENT OF CARDIOMYOPATHY | ZHU, JIANJIAN | 1631 | §103 | Non-Final OA | — | Pending | Feb 11, 2022 |
| 17632322 | METHODS OF BULK DROPLET VITRIFICATION | ABBOTT, KODYE LEE | 1634 | §102§103§112 | Non-Final OA | 1d overdue | Pending | Feb 02, 2022 |
| 17627975 | SELF-ASSEMBLED VACCINES AND COMBINATION THERAPIES FOR TREATING CANCER | LEE, YIE CHIA | 1642 | §103§112Other | Final Rejection | 78d | Pending | Jan 18, 2022 |
| 17626728 | ZEBRAFISH DELETION AND COMPOUND MUTANTS AND USES THEREOF | BEHARRY, ZANNA MARIA | 1632 | §101§103§112 | Non-Final OA | 9d overdue | Pending | Jan 12, 2022 |
| 17513640 | PREDICTING BREAST CANCER RECURRENCE | POHNERT, STEVEN C | 1683 | §103§112DP | Final Rejection | — | Pending | Oct 28, 2021 |
| 17434349 | TREATMENT OF BENIGN NERVOUS SYSTEM TUMORS USING ATTENUATED SALMONELLA TYPHIMURIUM | OGUNBIYI, OLUWATOSIN A | 1645 | §103 | Final Rejection | 50d overdue | Pending | Aug 26, 2021 |
| 17401623 | SYSTEMS AND METHODS FOR REMOVING EXOGENOUS PARTICLES FROM THE SKIN OF A PATIENT | PATEL, SHEFALI DILIP | 3783 | §103 | Non-Final OA | 79d | Pending | Aug 13, 2021 |
| 17296829 | T Cell-Directed Anti-Cancer Vaccines Against Commensal Viruses | SIFFORD, JEFFREY MARK | 1671 | §103§112Other | Non-Final OA | 61d | Pending | May 25, 2021 |
| 17330316 | SYSTEMS AND METHODS FOR EPIGENETIC SEQUENCING | CHUNDURU, SURYAPRABHA | 1683 | §112DP | Final Rejection | — | Pending | May 25, 2021 |
| 17294179 | CRISPR SYSTEM BASED DROPLET DIAGNOSTIC SYSTEMS AND METHODS | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103 | Final Rejection | 3d overdue | Pending | May 14, 2021 |
| 17270393 | MULTIFUNCTIONAL SKIN PATCH | MULLINS, JESSICA LYNN | 3792 | §103 | Non-Final OA | 43d overdue | Pending | Feb 22, 2021 |
| 17259659 | SYSTEM AND METHOD FOR MONITORING NEURAL SIGNALS | SHOSTAK, ANDREY | 3791 | §101§103 | Non-Final OA | — | Pending | Jan 12, 2021 |
| 17257391 | ANTIBODY TUMOR-TARGETING ASSEMBLY COMPLEXES | BRISTOL, LYNN ANNE | 1600 | Other | Non-Final OA | — | Pending | Dec 31, 2020 |
| 17254392 | CHIMERIC ANTIGEN RECEPTORS TARGETING CD37 AND CD19 | GUSTILO, ESTELLA M | 1646 | §101§102§103§112 | Final Rejection | 19d | Pending | Dec 21, 2020 |
| 17101028 | METHODS AND ASSAYS RELATING TO CIRCULATING TUMOR CELLS | DENT, ALANA HARRIS | 1643 | §103 | Final Rejection | — | Pending | Nov 23, 2020 |
| 16944588 | SYSTEMS AND METHODS THAT FACILITATE TATTOO REMOVAL | PATEL, SHEFALI DILIP | 3783 | §103 | Non-Final OA | 72d overdue | Pending | Jul 31, 2020 |
| 16487517 | METHODS OF PHOTOCHEMICAL TREATMENT FOR WOUND HEALING | SHIBUYA, MARK LANCE | 1631 | §103 | Non-Final OA | 22d | Pending | Aug 21, 2019 |
| 16349405 | SYSTEMS AND METHODS FOR MULTI-DISTANCE, MULTI-WAVELENGTH DIFFUSE CORRELATION SPECTROSCOPY | VIRK, ADIL PARTAP S | 3798 | §103§112 | Non-Final OA | 10d overdue | Pending | May 13, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial